Drug Profile
UCB 2892
Alternative Names: UCB2892Latest Information Update: 16 Mar 2011
Price :
$50
*
At a glance
- Originator UCB
- Class Small molecules
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS disorders
Most Recent Events
- 10 Aug 2010 Phase-I clinical trials in CNS disorders in United Kingdom (unspecified route)